Cryoport Systems on the state of the ATMP market and the importance of supply chain resilience

Beyond Biotech - the podcast from Labiotech

Content provided by Labiotech. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Labiotech or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

4M ago 48:30

MP3•Episode home

With supply chain management and optimization, risk management, and the capacity to address global markets efficiently and effectively top of mind for all growing biotechs, I'm excited to be joined by Alison Pritchard, Vice President, Business Development at Cryoport Systems, to learn more about how they support life science innovators worldwide.

Cryoport Systems evolved alongside the life science industry and expanded its capabilities into full-scale supply chain management solutions that support the critical journeys of the biopharmaceutical, reproductive medicine, and animal health markets.

In this episode we look at the ATMP market, the regulatory landscape in EMEA, and the importance of supply chain resilience for cutting edge therapies, whether from established pharmaceutical companies or emerging biotechs and startups.

00:02:14 The state of the ATMP market in 2025

00:07:20 Regulatory trends in EMEA

00:13:53 Operational and supply chain challenges

00:22:13 Lessons in supply chain resilience

00:28:56 Outsourcing trends in biotech

00:37:34 Geopolitical influences on the ATMP supply chain

00:40:39 Cryoport Systems' plans for the future

00:45:53 Final word

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

To dive deeper into the topic:

Chapters

1. Cryoport Systems on the state of the ATMP market and the importance of supply chain resilience (00:00:00)

2. The state of the ATMP market in 2025 (00:02:14)

3. Regulatory trends in EMEA (00:07:20)

4. Operational and supply chain challenges (00:13:53)

5. Lessons in supply chain resilience (00:22:13)

6. Outsourcing trends in biotech (00:28:56)

7. Geopolitical influences on the ATMP supply chain (00:37:34)

8. Cryoport Systems' plans for the future (00:40:39)

9. Final word (00:45:53)

172 episodes

#News #Tech News #Labiotech